The Obama administration placed India on a special trade blacklist Wednesday, a move some public health advocates said was retaliation for the country allowing generic versions of expensive drugs preferred by the U.S. government.
India’s generic drug industry, the world’s largest maker of low-cost medicines, has been the core of a public health revolution in the past decade, producing inexpensive versions of drugs used around the globe. Treatment for AIDS, in particular, was virtually nonexistent in developing countries prior to the emergence of Indian generic drug manufacturing in the early 2000s. The U.S. AIDS relief program, the President’s Emergency Plan for AIDS Relief, relies heavily on generic medications.
Another example of profit trumping life. Is this how we want to live? To be? Not sustainable. -tr